Meizhou Jiazhou Network Technology Co., LTD – Trademark Portfolio

Entity Type: 99

Meizhou Jiazhou Network Technology Co., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RMEGVCK. The owner is based in Meizhou City.

heng St .,Chengjiang Town,Meixian Dist

No.2, Huaxing Bldg.,1st Fl.,Tianxiu Er.

Meizhou City 514000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RMEGVCK
RMEGVCK
Registered 2024

Trademark Classifications

Meizhou Jiazhou Network Technology Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Meizhou Jiazhou Network Technology Co., LTD have?

Meizhou Jiazhou Network Technology Co., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Meizhou Jiazhou Network Technology Co., LTD file in?

Meizhou Jiazhou Network Technology Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Meizhou Jiazhou Network Technology Co., LTD's most well-known trademarks?

Meizhou Jiazhou Network Technology Co., LTD's registered trademark portfolio includes well-known marks such as RMEGVCK. These are among 1 currently registered trademark in the portfolio.

What is Meizhou Jiazhou Network Technology Co., LTD's trademark registration success rate?

Meizhou Jiazhou Network Technology Co., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.